
Please try another search
Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Angela Hildreth | 45 | 2018 | COO, Finance Director, Company Secretary & Executive Director |
Kenneth William James | 73 | 2016 | Head of R&D & Executive Director |
Andrew Vaughan Unitt | 68 | 2022 | Senior Independent Non-Executive Director |
Gordon Roy Davis | 69 | 2024 | Independent Non-Executive Director |
Harmesh Kumar Suniara | 55 | 2025 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review